Olfactory cells can act as “Trojan Horse” to deliver anticancer payload to the brain

Glioblastomas are an aggressive form of primary tumors that arise in the central nervous system. Glioblastomas are resistant to current modalities of treatment (i.e. surgery, chemotherapy, and radiation therapy) and have one of the worst 5-year survival rates. One challenge in treating glioblastomas is delivering anticancer agents to the brain, which is protected by the